Links：https://www.miltenyibiotec.com/US-en/lp/sars-cov-2-peptivato ...
SARS‑CoV‑2 PepTivator® Peptide Pools
SARS-CoV-2 PepTivator Peptide Pools can be used to investigate T cell immunity in COVID-19 after natural infection or vaccination. Load antigen-presenting cells with the peptides and stimulate SARS-CoV-2–specific T cells. The T cells can then be detected and/or isolated for further research, including analysis of T cell immune response after vaccination or monitoring the immune status after infection. We provide different peptide pools covering specified proteins parts of wild-type and mutated SARS-CoV-2 variants. 0)
Fig 1. Lights Clinical Trial For COVID-19 Coronavirus Treatment That ‘Flattens The Curve’ In Patients (Link: https://ppt.cc/fIwlhx)
Fig 2. A potent, coronavirus-targeted T-cell product that is safe for patients and has the potential to treat SARS-CoV-2 infections in immunocompromised individuals (Link: https://ppt.cc/fCPpYx)
Structure of Coronavirus:
SARS‑CoV‑2 PepTivator® Products:
Order no. | Product | Size |
130-126-700 | PepTivator SARS‑CoV‑2 Prot_S | 6 nmol per peptide pre vial |
130-126-701 | PepTivator SARS‑CoV‑2 Prot_S | 60 nmol per peptide pre vial |
130-126-698 | PepTivator SARS‑CoV‑2 Prot_N | 6 nmol per peptide pre vial |
130-126-699 | PepTivator SARS‑CoV‑2 Prot_N | 60 nmol per peptide pre vial |
130-126-702 | PepTivator SARS‑CoV‑2 Prot_M | 6 nmol per peptide pre vial |
130-126-703 | PepTivator SARS‑CoV‑2 Prot_M | 60 nmol per peptide pre vial |
Antigen-specific in vitro stimulation:
Order no. | Product | Size |
130-092-658 | CD154 Microbeads kit | for positive selection of activated CD154+ antigen-specific CD4+ T cells from human PBMCs |
130-093-476 | CD137 MicroBead Kit | for the positive selection of human CD137+ cells from PBMCs |
130-054-201 | IFN-γ Secretion Assay | for the sensitive detection as well as the enrichment of human IFN-γ-secreting cells |